A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients.

Autor: Erken R; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Meibergdreef 9, Amsterdam, the Netherlands., Loukachov VV; Department of Experimental Immunology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., de Niet A; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Jansen L; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Stelma F; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Helder JT; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Peters MW; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Zaaijer HL; Sanquin Blood Supply Foundation, Plesmanlaan 125, Amsterdam, the Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands., Willemse SB; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Meibergdreef 9, Amsterdam, the Netherlands., Reesink HW; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2022 May-Jun; Vol. 12 (3), pp. 735-744. Date of Electronic Publication: 2022 Jan 04.